Diagnostic and clinical significance of D2-40 expression in the normal human thymus and thymoma

Romanian Journal of Morphology and Embryology

Volumn 51, Issue 2, 2010, Pages 229-234

  Raica, M ^a   Kondylis, A ^a   Mogoanta L ^b   Encicǎ, Svetlana ^c   Cl̂mpean, Anca Maria ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^c Niculae Stancioiu Heart Institute   (Romania)

Author keywords

D2 40; Immunohistochemistry; Prognosis; Thymoma; Thymus

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY D2-40;

ARTICLE; BIOSYNTHESIS; CHILD; FETUS; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; METABOLISM; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; THYMOMA; THYMUS;

ANTIBODIES, MONOCLONAL; CHILD; CHILD, PRESCHOOL; FETUS; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; PROGNOSIS; THYMOMA; THYMUS GLAND;

EID: 77953062032     PISSN: 12200522     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Blackburn CC, Manley NR, Developing a new paradigm for thymus organogenesis, Nat Rev Immunol, 2004, 4(4):278-289.
2. Jenkinson WE, Jenkinson EJ, Anderson G, Differential requirement for mesenchyme in the proliferation and maturation of thymic epithelial progenitors, J Exp Med, 2003, 198(2):325-332.
3. th edition, Mosby, St. Louis, 2004, 462-484.
4. rd edition, Lippincott Williams & Wilkins, Philadelphia, 2007, 505-526.
5. Hale LP, Histologic and molecular assessment of human thymus, Ann Diagn Pathol, 2004, 8(1):50-60.
6. Chen FF, Yan JJ, Jin YT, Su IJ, Detection of bcl-2 and p53 in thymoma: expression of bcl-2 as a reliable marker of tumor aggressiveness, Hum Pathol, 1996, 27(10):1089-1092.
7. Raica M, Encica S, Mogoanta L, Suciu C, Cîmpean AM, Mǎrgǎritescu C, Thymus and thymoma: what's new?, Rom J Morphol Embryol, 1999-2004, XLV:11-24.
8. Pan CC, Chen PC, Chiang H, KIT (CD117) is frequently overexpressed in thymic carcinomas but is absent in thymomas, J Pathol, 2004, 202(3):375-381.
9. Yoshino N, Kubokura H, Yamauchi S, Oaki Y, Koizumi K, Shimizu K, Type B3 thymic epithelial tumor in an adolescent detected by immunohistochemical staining for CD5, CD99, and KIT (CD117): a case report, Ann Thorac Cardiovasc Surg, 2009, 15(5):324-327.
10. Rosai J, Histological typing of tumours of the thymus, WHO International Histological Classification of Tumours, Springer-Verlag, Berlin, 1999.
11. Marks a, Sutherland DR, Bailey D, Iglesias J, Law J, Lei M, Yeger H, Banerjee D, Baumal R, Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours, Br J Cancer, 1999, 80(3-4):569-578.
12. Xuan M, Fang YR, Wato M, Hata S, Tanaka a, Immuno-histochemical co-localization of lymphatics and blood vessels in oral squamous cell carcinomas, J Oral Pathol Med, 2005, 34(6):334-339.
13. Raica M, Cimpean AM, Ribatti D, The role of podoplanin in tumor progression and metastasis, Anticancer Res, 2008, 28(5B):2997-3006.
14. Kato Y, Kaneko MK, Kuno a, Uchiyama N, Amano K, Chiba Y, Hasegawa Y, Hirabayashi J, Narimatsu H, Mishima K, Osawa M, Inhibition of tumor cell-induced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domain, Biochem Biophys Res Commun, 2006, 349(4):1301-1307.
15. Breiteneder-Geleff S, Soleiman a, Kowalski H, Horvat R, Amann G, Kriehuber E, Diem K, Weninger W, Tsachler E, Alitalo K, Kerjaschki D, Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium, Am J Pathol, 1999, 154(2):385-394.
16. Kimura N, Kimura I, Podoplanin as a marker for meso- thelioma, Pathol int, 2005, 55(2): 83-86.
17. Mishima K, Kato Y, Kaneko MK, Nakazawa Y, Kunita A, Fujita N, Tsuruo T, Nishikawa R, Hirose T, Matsutani M, Podoplanin expression in primary central nervous system germ cell tumors: a useful histological marker for the diagnosis of germinoma, Acta Neuropathol, 2006, 111(6):563-568.
18. Schacht V, Dadras SS, Johnson LA, Jackson DG, Hong YK, Detmar M, Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors, Am J Pathol, 2005, 166(3):913-921.
19. Shibahara J, Kashima T, Kikuchi Y, Kunita A, Fukayama M, Podoplanin is expressed in subsets of tumors of the central nervous system, Virchows Arch, 2006, 448(4):493-499.
20. Raica M, Cîmpean AM, Encicǎ S, Cornea R, Involution of the thymus: a possible diagnostic pitfall, Rom J Morphol Embryol, 2007, 48(2):101-106.
21. + epithelial cell progenitors and by increased expression of Trp63, cMyc and Tcf3 transcription factors in the thymic stroma, Int Immunol, 2007, 19(11):1249-1260.
22. Cimpean AM, Raica M, Encica S, Cornea R, Bocan V, Immunohistochemical expression of vascular endothelial growth factor A (VEGF), and its receptors (VEGFR1, 2) in normal and pathologic conditions of the human thymus, Ann Anat, 2008, 190(3):238-245.
23. Suzuki E, Sasaki H, Kawano O, Endo K, Haneda H, Yukiue H, Kobayashi Y, Yano M, Fujii Y, Expression and mutation statuses of epidermal growth factor receptor in thymic epithelial tumors, Jpn J Clin Oncol, 2006, 36(6):351-356.
24. Raica M, Cimpean AM, Platelet derived growth factor (PDGF)/PDGF receptors (PDGFR) axis as target for anti-tumor and antiangiogenic therapy, Pharmaceuticals, 2010, 3(3):572-599.
25. Suzuki-Inoue K, Kato Y, Inoue O, Kaneko MK, Mishima K, Yatomi Y, Yamazaki Y, Narimatsu H, Ozaki Y, Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells, J Biol Chem, 2007, 282(36):25993-26001.
26. Kato Y, Kaneko MK, Kunita A, Ito H, Kameyama A, Ogasawara S, Matsuura N, Hasegawa Y, Suzuki-Inoue K, Inoue O, Ozaki Y, Narimatsu H, Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2, Cancer Sci, 2008, 99(1):54-61.
27. Wicki A, Christofori G, The potential role of podoplanin in tumour invasion, Br J Cancer, 2007, 96(1):1-5.
28. Wicki A, Lehembre F, Wick N, Hantusch B, Kerjanschki D, Christofori G, Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton, Cancer Cell, 2006, 9(4):261-272.
29. Moustakas A, Heldin CH, Signaling networks guiding epi-thelial-mesenchymal transitions during embryogenesis and cancerprogression, Cancer Sci, 2007, 98(10):1512-1520